AI
| Followers | 323 |
| Posts | 13293 |
| Boards Moderated | 1 |
| Alias Born | 11/29/2010 |
Monday, December 19, 2011 8:13:35 AM
AGEN NEWS TODAY. Agenus and ChemRar Enter into Agreement in the Area of Personalized Cancer Vaccines.
Under the agreement, Agenus has granted NewVac an exclusive license to manufacture, market and sell Oncophage as well as pursue a development program of Oncophage in combination with NewVac’s co-adjuvant technology in the Russian Federation and CIS countries. Agenus is entitled to receive a transfer price and/or royalties upon Oncophage product sales, and potential milestone payments.
Under the agreement, Agenus has granted NewVac an exclusive license to manufacture, market and sell Oncophage as well as pursue a development program of Oncophage in combination with NewVac’s co-adjuvant technology in the Russian Federation and CIS countries. Agenus is entitled to receive a transfer price and/or royalties upon Oncophage product sales, and potential milestone payments.
1% Stocks I-Hub
Trading ideas are not recommendations to buy or sell.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
